3,4-Disubstituted-4-aryl-piperidine compounds are disclosed.
Pharmaceutical compositions containing the
3,4-disubstituted-4-aryl-piperidine compounds and methods of their
pharmaceutical uses are also disclosed. The compounds disclosed are
useful, inter alia, as antagonists of opioid receptors.